Literature DB >> 22033494

Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies.

S Sinha, M A Gertz, M Q Lacy, A Dispenzieri, S R Hayman, F K Buadi, D Dingli, I N Micallef, W J Hogan, D A Gastineau, S V Rajkumar, S K Kumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22033494     DOI： 10.1038/leu.2011.308

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Hematopoietic progenitor cell mobilization with "just-in-time" plerixafor approach is a cost-effective alternative to routine plerixafor use.

Authors:  Lauren Veltri; Aaron Cumpston; Alexandra Shillingburg; Sijin Wen; Jin Luo; Sonia Leadmon; Kathy Watkins; Michael Craig; Mehdi Hamadani; Abraham S Kanate
Journal:  Cytotherapy       Date:  2015-10-21       Impact factor: 5.414

Review 2.  Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation.

Authors:  M Mohty; K Hübel; N Kröger; M Aljurf; J Apperley; G W Basak; A Bazarbachi; K Douglas; I Gabriel; L Garderet; C Geraldes; O Jaksic; M W Kattan; Z Koristek; F Lanza; R M Lemoli; L Mendeleeva; G Mikala; N Mikhailova; A Nagler; H C Schouten; D Selleslag; S Suciu; A Sureda; N Worel; P Wuchter; C Chabannon; R F Duarte
Journal:  Bone Marrow Transplant       Date:  2014-03-31       Impact factor: 5.483

3.  Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study.

Authors:  Pellegrino Musto; Vittorio Simeon; Alberto Grossi; Francesca Gay; Sara Bringhen; Alessandra Larocca; Roberto Guariglia; Giuseppe Pietrantuono; Oreste Villani; Giovanni D'Arena; Carmela Cuomo; Clelia Musto; Fortunato Morabito; Maria Teresa Petrucci; Massimo Offidani; Elena Zamagni; Paola Tacchetti; Concetta Conticello; Giuseppe Milone; Antonio Palumbo; Michele Cavo; Mario Boccadoro
Journal:  Stem Cell Res Ther       Date:  2015-04-17       Impact factor: 6.832

Review 4.  Peripheral blood stem cell mobilization in multiple myeloma: Growth factors or chemotherapy?

Authors:  Whitney D Wallis; Muzaffar H Qazilbash
Journal:  World J Transplant       Date:  2017-10-24

5.  High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group.

Authors:  Iwona Hus; Joanna Mańko; Dariusz Jawniak; Artur Jurczyszyn; Grzegorz Charliński; Katarzyna Poniewierska-Jasak; Lidia Usnarska-Zubkiewicz; Mateusz Sawicki; Agnieszka Druzd-Sitek; Alina Świderska; Anna Kopińska; Norbert Grząśko; Małgorzata Raźny; Aleksandra Wędłowska; Aleksander Perzyński; Aleksandra Gałązka; Dominik Dytfeld; Tadeusz Kubicki; Marek Rodzaj; Anna Waszczuk-Gajda; Joanna Drozd-Sokołowska; Bartłomiej Pogłódek; Anna Pasternak; Monika Długosz-Danecka; Agnieszka Szymczyk; Anna Dmoszyńska
Journal:  Oncol Lett       Date:  2019-09-27       Impact factor: 2.967
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.